A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke

NCT05188417 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

266

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: Tirofiban 0.05 MG/ML
DRUG: 0.9% sodium chloride solution

Sponsor

GrandPharma (China) Co., Ltd.